Ketamine Irrigation Analgesia in Laparoscopic Cholecystectomy
Condition(s) studied
Investigational drug(s) / intervention(s)
Normal saline: Patients will receive the irrigation at the end of surgery after dissection; irrigation analgesia by 5 ml bupivacaine 0.50% plus 20 ml normal saline (Group N)
Ketamine: Patients will receive 5 ml bupivacaine 0.50% plus 1 mg/kg ketamine (Group K). The volume of irrigation in group K is completed by normal saline to reach a total of 25 ml.
Study summary
Patients will be assigned randomly to two groups (30 subjects each) to be anesthetized. The study drug will be delivered in opaque bags labeled "study drug" and 60 patients will be allocated in two groups (of 30 patients each) to receive the irrigation at the end of surgery after dissection; irrigation analgesia by 5 ml bupivacaine 0.50% plus 20 ml normal saline (Group N) or 5 ml bupivacaine 0.50% plus 1 mg/kg ketamine (Group K). The volume of irrigation in group K is completed by normal saline to reach a total of 25 ml.
Eligibility
Primary outcome measure(s)
- The total consumption of rescue analgesics — 24 hours
The total consumption of postoperative rescue analgesics was recorded from the time to first request rescue analgesia to patient discharge after 24 h. - Systemic inflammatory response via Neutrophil-to-lymphocyte ratio (NLR) — 24 hours (One reading preoperative as a baseline and a second reading 24 hours postoperatively).
Evaluation of the anti-inflammatory effect of intraperitoneal ketamine irrigation by measuring changes in the Neutrophil-to-Lymphocyte Ratio (NLR). NLR is calculated by dividing the absolute neutrophil count by the absolute lymphocyte count from a standard complete blood count (CBC).
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Assiut University | Asyut | Assuit |
More Assiut University trials in Egypt
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07370181 on ClinicalTrials.gov ↗ ← All trials in Egypt